Ionis Pharmaceuticals Drops Another After Phase 3 Setback
Ionis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
Tracking monthly expenses reveals spending patterns and helps you control costs. Start today to build stronger financial habits and clarity.
26,700 articlesIonis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
AI-driven capital spending and the wealth boost from tech stocks are accelerating U.S. GDP growth. Analysts say the d...
Oil volatility tied to Middle East tensions is raising fuel costs and could push grocery prices higher. Here’s what s...
As Iran-related conflict enters its fourth week, airlines brace for a fuel-cost shock even as travelers return and fa...
Moderna shares rose about 6% early trading after better-than-expected Q1 results and renewed vaccine interest. Pfizer...
Berkshire Hathaway sold stocks in Q1, exiting 16 positions as the conglomerate maintains a heavy concentration in sev...
Dell Technologies shares have surged about 120% in a blistering run, pushing the stock toward record levels as AI inf...
Tensions abroad sparked fears of a jet fuel shortage, but industry data and regulators say the fuel crisis never exis...
As MiCA tightens EU crypto rules, licensed platforms race to absorb deposits from non-compliant venues. european cryp...
Apple files a lawsuit against OpenAI over alleged trade-secrets theft. Jim Cramer calls the move heavyweight, signali...
Trump’s tariff threat makes markets pivot, accelerating a rotation from U.S. stocks to international equities. The Va...
Oil prices jumped above $100 per barrel on Iran-related tensions, then cooled as traders reassessed supply risks and ...